BioHealth News Archive
Study upgrades one of the largest databases of neuronal types
A study led by researchers from the Institute Cajal of Spanish Research Council (CSIC) in Madrid, Spain in collaboration with the Bioengineering Department of…
Read More
Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College Park and Baltimore, Joins Rich Bendis on a New Episode of BioTalk
Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College Park and Baltimore, Visits BioTalk to Discuss Her Career,…
Read More
In Conversation: Montgomery County, Maryland Executive Marc Elrich · BioBuzz
Montgomery County (MOCO), Maryland, sits at the epicenter of biopharma growth, investment, and innovation that makes the BioHealth Capital Region (BHCR) one of the…
Read More
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® (ustekinumab) Biosimilar | Business Wire
FREDERICK, Md.--(BUSINESS WIRE)--BioFactura, a leading developer of high-value biosimilar and biodefense drugs using its patented StableFastTM platform, announces today the initiation of a pivotal…
Read More
NIH spinout raises millions to attack drug-resistant cancers with RNA. It has big plans. · BioBuzz
A local biotech has secured millions of dollars in new investments to take its RNA therapies for drug-resistant cancers to the clinic. Gaithersburg’s miRecule Inc. has…
Read More
miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy
Gaithersburg, MD. (May ____ 2021) miRecule, Inc. (“miRecule”), an emerging biotech company focused on the development of cutting-edge RNA therapeutics, announced today it has…
Read More
NIH spinout fighting cancer with RNA therapeutics raises millions – Washington Business Journal
The startup is developing therapeutics for drug-resistant cancers — and applying its technology to other arenas, including Covid-19. Image: MiRecule CEO Anthony Saleh, shown…
Read More
Biohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9)
Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding to advance your technology? Learn more about whether or…
Read More
Biohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9)
Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding to advance your technology? Learn more about whether or…
Read More
RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium
RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems for cell and gene therapy product…
Read More
BHI NIH Entrepreneur-In-Residence Job Opening
BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets.…
Read More
BHI NIH Entrepreneur-In-Residence Job Opening
BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets.…
Read More
BHI EIR Feedback Day May 26th. – Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read More
BHI EIR Feedback Day May 26th. – Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read More
Blu Ventures Launches $25M Venture Capital Fund Focused on Cybersecurity
Blu Venture Investors, a Vienna, VA-based venture capital firm supporting the cybersecurity ecosystem in the Mid-Atlantic region and beyond, launched a $25M fund. The BVI Cyber…
Read More